News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elan Pharmaceuticals (ELN) Reports Second Quarter and First Half 2013 Financial Results


7/24/2013 6:35:25 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Elan Corporation, plc (NYSE:ELN) today reported its second quarter and first half 2013 financial results.

“We are focused squarely on the process of exploring a sale of the company as announced by our Board of Directors on June 14, 2013,” commented Mr. Kelly Martin, CEO, adding, “the Board of Directors and executive management are in complete alignment with regard to exploring all opportunities to maximize shareholder value.”

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES